Earlier this month Aldevron hosted its first scientific conference, the Breakthrough Symposium. We felt the time was right, given 2018 is Aldevron’s 20th anniversary, to invite those in the gene and cell therapy fields to Fargo, North Dakota, for collaboration, networking and fellowship. We were overwhelmed and gratified by the response!
Aldevron is privileged to work with some of the most innovative and groundbreaking companies, academic institutions, and government laboratories in biotechnology today. Since the company’s founding 20 years ago, Michael Chambers and John Ballantyne have always focused on clients, with the goal to improve the lives of the customers and patients they serve. Researchers across the globe are making tremendous breakthroughs in gene and cell therapy and gene editing, resulting in advances in medicine, agriculture, energy and many other fields. We are honored to serve as the basis for many of these transformative products.